VaramirStart free · no cardSign in
BCRX as of Nov 1 · 14:12 ET
BCRXNasdaqBiological Products, (No Diagnostic Substances)

Biocryst Pharmaceuticals Inc · Brief

Next report

1 day

Nov 2 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±11.5%
avg realized
±7.6%
May 5 '25±10.6%▲+23.52%×2.22
Aug 4 '25±24.6%▲+9.81%×0.40
Oct 14 '25±8.6%▼−8.81%×1.02
Nov 3 '25±14.2%▼−6.28%×0.44
Jan 12 '26±7.9%▼−4.80%×0.61
Q1 FY26±7.0%▲+4.64%×0.66
May 6 '26±8.9%▼−2.21%×0.25
Q2 FY26±10.0%▲+0.55%×0.05
quarterimplied−25%0+25%realized×
Q2 FY26±10.0%▲+0.55%×0.05
May '26±8.9%▼−2.21%×0.25
Q1 FY26±7.0%▲+4.64%×0.66
Jan '26±7.9%▼−4.80%×0.61
Nov '25±14.2%▼−6.28%×0.44
Oct '25±8.6%▼−8.81%×1.02
2 older reports
Aug '25±24.6%▲+9.81%×0.40
May '25±10.6%▲+23.52%×2.22
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 2 report · est.

Bull2 of 3

318managers reporting a position in the latest quarterly filings13F · Jun 30 '26
34managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

Bear2 of 3

5tracked funds holding BCRXN-PORT · Aug 31 '26
0.89%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

BCRX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 19impliedImplied move: ±10.9% into Nov 2 earnings (Oct 19 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.